Literature DB >> 15319678

Sexual risk reduction in a cohort of injecting drug users in Bangkok, Thailand.

Suphak Vanichseni1, Don C Des Jarlais, Kachit Choopanya, Philip A Mock, Dwip Kitayaporn, Udomsak Sangkhum, Boonrawd Prasithiphol, Dale J Hu, Frits van Griensven, Timothy D Mastro, Jordan W Tappero.   

Abstract

OBJECTIVE: Interventions to reduce sexual risk behavior among injecting drug users (IDUs) have generally had very modest effects, but almost all such interventions have been conducted within short time frames. This study assessed whether long-term participation in interventions to reduce sexual risk behavior was associated with reduced sexual risk behavior.
METHODS: A total of 806 IDUs participated in the Bangkok HIV Vaccine Trial Preparatory Cohort Study from 1995-1998 and remained in the study for at least 4 follow-up visits (approximately 16 months). Participants received HIV counseling and testing every 4 months and free condoms were provided. Structured interviews including questions on sexual behavior were administered every 4 months.
RESULTS: Approximately 40% of participants reported engaging in unprotected sex (vaginal intercourse without always using a condom) with a regular partner at each study visit, without any decline over time in this behavior. There were declines in the proportions of participants reporting unprotected sex with casual partners and with paid partners (men only) over time, but the declines were confined to the early period of the study. Unprotected sex with casual partners was associated with amphetamine use. Condom use increased substantially among participants who seroconverted for HIV during the study.
CONCLUSIONS: Interventions to reduce sexual risk behavior among HIV-seronegative IDUs over extended periods were no more likely to be effective than shorter interventions. New programs are needed to reduce sexual risk behavior among amphetamine users and among IDUs who are currently seronegative but are engaging in injection risk behaviors and in unprotected sex with regular partners.

Entities:  

Mesh:

Year:  2004        PMID: 15319678     DOI: 10.1097/01.qai.0000120821.38576.ec

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  5 in total

1.  Human immunodeficiency virus (HIV) infection patterns and risk behaviours in different population groups and provinces in Viet Nam.

Authors:  Nguyen Anh Tuan; Knut Fylkesnes; Bui Duc Thang; Nguyen Tran Hien; Nguyen Thanh Long; Nguyen Van Kinh; Pham Hong Thang; Pham Duc Manh; Nigel O'Farrell
Journal:  Bull World Health Organ       Date:  2007-01       Impact factor: 9.408

2.  Needle exchange and sexual risk behaviors among a cohort of injection drug users in Chicago, Illinois.

Authors:  Dezheng Huo; Lawrence J Ouellet
Journal:  Sex Transm Dis       Date:  2009-01       Impact factor: 2.830

3.  HIV Incidence and Risk Behaviours of People Who Inject Drugs in Bangkok, 1995-2012.

Authors:  Michael Martin; Suphak Vanichseni; Udomsak Sangkum; Philip A Mock; Manoj Leethochawalit; Sithisat Chiamwongpaet; Punnee Pitisuttithum; Jaranit Kaewkungwal; Frits van Griensven; Janet M McNicholl; Jordan W Tappero; Timothy D Mastro; Somyot Kittimunkong; Kachit Choopanya
Journal:  EClinicalMedicine       Date:  2019-04-01

4.  Halting HIV/AIDS with avatars and havatars: a virtual world approach to modelling epidemics.

Authors:  Richard Gordon; Natalie K Björklund; Robert J Smith; Eluemuno R Blyden
Journal:  BMC Public Health       Date:  2009-11-18       Impact factor: 3.295

5.  Risk Factors for Loss to Follow-Up among People Who Inject Drugs in a Risk Reduction Program at Karachi, Pakistan. A Case-Cohort Study.

Authors:  Rab Nawaz Samo; Ajmal Agha; Sharaf Ali Shah; Arshad Altaf; Ashraf Memon; Meridith Blevins; Han-Zhu Qian; Sten H Vermund
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.